Shares of VIVUS, Inc. (Nasdaq: VVUS) are getting pounded for the second straight session after Citron Research raised questions about ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE